Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.
Schlagwort-Archiv: CNBC
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.
Oil major BP posts 70% drop in second-quarter profit, raises dividend by 10%
Oil majors have failed to match the bumper profits posted during the same period of last year amid weaker commodity prices.
Francisco Partners & TPG to take New Relic private in $6 billion deal
The consortium offered $87 per share in an all-cash deal to take New Relic private on Monday.
Stocks making the biggest moves premarket: Hasbro, Adobe, GoodRx, SBA Communications and more
These are the stocks posting the largest moves in early trading.
Robinhood rival eToro agrees $120 million share sale at discounted valuation
Stock trading platform eToro agreed to a $120 million secondary share sale giving it a slightly lower valuation than the $3.5 billion it was last valued at.
A.I. is on a collision course with white-collar, high-paid jobs — and with unknown impact
Technology has disrupted many workplaces. Artificial intelligence like ChatGPT may have an outsized impact on higher-paid office jobs, experts said.
The fight over a bill targeting credit card fees pits payment companies against retailers
Bipartisan support for the Credit Card Competition Act has surged since it was introduced last year.
Top Wall Street analysts are upbeat about these dividend stocks
TipRanks analyst ranking service pinpoints Wall Street’s best-performing stocks, including IBM and Morgan Stanley.
Why substituting cryptocurrency for gold exposure may be a costly mistake
State Street Global Advisors‘ George Milling-Stanley, whose firm runs the world’s largest gold ETF, gives his bull case for the precious metal.